Treatment adherence in the recurrent depressive disorders;Observance thérapeutique dans les troubles dépressifs récurrents

Encephale

Volumn 28, Issue 3 I, 2002, Pages 255-259

  Spadone, C ^a  

^a FOCH HOSPITAL   (France)

Author keywords

Compliance; Continuation therapy; Depression; Prevention of relapse

Indexed keywords

ANTIDEPRESSANT AGENT; IMIPRAMINE; LITHIUM; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; PATIENT COMPLIANCE; RECURRENT DISEASE; RELAPSE; REVIEW; RISK BENEFIT ANALYSIS;

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; DEPRESSIVE DISORDER; HUMANS; LONG-TERM CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; RECURRENCE; TREATMENT OUTCOME;

EID: 0036313905     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Long term pharmacotherapy of depression
2. Fluvoxamine and lithium in long term treatment of unipolar subjects with high recurrence rate
3. Dose-response efficacy of paroxetine in preventing depressive recurrence: A randomized, double-blind study
4. Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or dealy new depressive episode
5. Four year follow up study of sertraline and fluvoxamine in long term treatment of unipolar subjects with high recurrence rate
6. Two-year maintenance treatment with citalopram, 20 mg, in unipolar subject with high recurrence rate
7. Three year outcome for maintenance therapies in recurrent depression
8. Continuation therapy with lithium and amitriptyline in unipolar depressive illness
9. Maintenance phase efficacy or sertraline for chronic depression: A randomized controlled trial
10. Sertraline vs imipramine to prevent relapse in chronic depression
11. Five year outcome for maintenance therapies in reccurent depression
12. The interaction of drug-and psychotherapy in the long term treatment of depression
13. Paroxetine is better than placebo in relapse prevention and the prophylaxis or recurrent depression
14. Mirtazapine vs amitriptyline in the long term treatment of depression: A double blind placebo controlled study
15. Fluoxetine vs placebo: Long term treatment of MMD
16. Minalcipran efficacy in the prevention of recurrent depression: A 12 month placebo controlled study
17. Fluvoxamine prevents recurrence of depression: Results of a long-term, double-blind, placebo-controlled study